Drug intelligence / Profile preview

Gua Xie Xin Tong dripping pills

Development stage: Unknown
Lead developer: Heilongjiang Xinyisheng Pharmaceutical
Administration: Oral

Overview

Gua Xie Xin Tong dripping pills is a traditional Chinese medicine (TCM) therapeutic being developed for the treatment of chronic stable angina pectoris and coronary artery disease. The drug is formulated as oral dripping pills and is specifically targeted at patients with the TCM syndrome of phlegm-blood stasis obstructing collaterals. It has undergone Phase II clinical testing in China, specifically evaluating its efficacy in patients with Canadian Cardiovascular Society (CCS) class I–II exertional angina. The development is a collaborative effort between Heilongjiang Xinyisheng Pharmaceutical and Beijing Herun Innovation Pharmaceutical Technology Development.

Beyond the preview

Go deeper on Gua Xie Xin Tong dripping pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gua Xie Xin Tong dripping pills.

Explore the full profile